IL97403A0 - 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them - Google Patents
3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing themInfo
- Publication number
- IL97403A0 IL97403A0 IL97403A IL9740391A IL97403A0 IL 97403 A0 IL97403 A0 IL 97403A0 IL 97403 A IL97403 A IL 97403A IL 9740391 A IL9740391 A IL 9740391A IL 97403 A0 IL97403 A0 IL 97403A0
- Authority
- IL
- Israel
- Prior art keywords
- imidazolidinones
- oxazolidinones
- hydroxyphenylmethylene
- tertiarybutyl
- derivatives
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- -1 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene Chemical class 0.000 title abstract 2
- 150000008624 imidazolidinones Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 abstract 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 abstract 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 abstract 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/40—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49993790A | 1990-03-27 | 1990-03-27 | |
| US07/640,711 US5143928A (en) | 1990-03-27 | 1991-01-18 | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL97403A0 true IL97403A0 (en) | 1992-06-21 |
Family
ID=27053353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL97403A IL97403A0 (en) | 1990-03-27 | 1991-03-04 | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US5143928A (da) |
| EP (1) | EP0449216B1 (da) |
| JP (1) | JP3028628B2 (da) |
| KR (1) | KR0156533B1 (da) |
| CN (1) | CN1055180A (da) |
| AT (1) | ATE133945T1 (da) |
| AU (1) | AU640468B2 (da) |
| CA (1) | CA2039056C (da) |
| DE (1) | DE69116909T2 (da) |
| DK (1) | DK0449216T3 (da) |
| ES (1) | ES2082875T3 (da) |
| FI (1) | FI103508B (da) |
| GR (1) | GR3019272T3 (da) |
| HU (1) | HU911001D0 (da) |
| IE (1) | IE911006A1 (da) |
| IL (1) | IL97403A0 (da) |
| NO (1) | NO302294B1 (da) |
| NZ (1) | NZ237565A (da) |
| PT (1) | PT97169B (da) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
| EP0915090A1 (en) * | 1992-09-10 | 1999-05-12 | Eli Lilly And Company | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
| AU672047B2 (en) * | 1992-10-06 | 1996-09-19 | Ciba-Geigy Ag | Novel thiosemicarbazonethiones |
| US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
| US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| JP3871354B2 (ja) * | 1994-07-29 | 2007-01-24 | 株式会社フジモト・コーポレーション | 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体 |
| TW424087B (en) * | 1995-04-06 | 2001-03-01 | Janssen Pharmaceutica Nv | 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives |
| NZ332763A (en) * | 1996-07-11 | 2000-07-28 | Warner Lambert Co | Treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| US6218437B1 (en) | 1996-09-30 | 2001-04-17 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
| EP1006794B1 (en) * | 1997-03-12 | 2007-11-28 | Robert W. Esmond | A method for treating or preventing alzheimer's disease |
| US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
| MY122454A (en) * | 1998-06-05 | 2006-04-29 | Upjohn Co | Use of oxazolidinones for the preparation of a medicament for transdermal delivery |
| US6191154B1 (en) | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
| US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
| UA66401C2 (en) | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
| JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
| US6444685B1 (en) | 2000-07-17 | 2002-09-03 | Wyeth | N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
| US7041650B2 (en) * | 2001-07-09 | 2006-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivative salts |
| JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
| MXPA02010430A (es) | 2001-11-27 | 2003-06-02 | Warner Lambert Co | Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas. |
| MXPA05005406A (es) * | 2002-11-22 | 2005-08-03 | Smithkline Beecham Corp | Compuestos quimicos novedosos. |
| US7479507B2 (en) * | 2003-01-14 | 2009-01-20 | Adam Heller | Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs |
| JP4570857B2 (ja) * | 2003-03-31 | 2010-10-27 | 富士フイルム株式会社 | 感光性組成物及び平版印刷版原版 |
| EP2671507A3 (en) | 2005-04-28 | 2014-02-19 | Proteus Digital Health, Inc. | Pharma-informatics system |
| CN100384828C (zh) * | 2005-05-08 | 2008-04-30 | 山东大学 | (z)-5-[[(3,5-二叔丁基)-4-羟基苯基]亚甲基]-2-亚氨基-4-噻唑啉酮甲磺酸盐的制备方法 |
| PE20070083A1 (es) * | 2005-06-08 | 2007-01-27 | Smithkline Beecham Corp | (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)amino]-1,3-tiazol-4(5h)-ona |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| US20100286041A1 (en) * | 2007-03-22 | 2010-11-11 | Smithkline Beecham Corporation | (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| FR2919608B1 (fr) * | 2007-08-01 | 2012-10-05 | Univ Rennes | Derives d'imidazolones,procede de preparation et applications biologiques |
| CA2752373C (en) | 2009-02-20 | 2017-10-10 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| CN102000487B (zh) * | 2010-10-19 | 2012-09-05 | 上海海事大学 | 一种捕捉二氧化碳的方法 |
| CN103044352B (zh) * | 2011-10-13 | 2015-04-29 | 南京大学 | 一类噻唑啉酮衍生物及其制法 |
| ES2668310T3 (es) | 2012-11-05 | 2018-05-17 | Commissariat à l'énergie atomique et aux énergies alternatives | Combinación de un agente anticanceroso tal como un inhibidor de la tirosina cinasa y un antagonista STAT5, preferiblemente una tiazolidindiona, para eliminar las células madre de cáncer hematológico in vivo y para prevenir la recidiva de cáncer hematológico |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
| DE3013626C2 (de) * | 1980-04-09 | 1985-06-27 | Degussa Ag, 6000 Frankfurt | Verfahren zur Herstellung von 5-Arylidenhydantoinen (A) |
| DE3013647C2 (de) * | 1980-04-09 | 1985-07-11 | Degussa Ag, 6000 Frankfurt | Verfahren zur Herstellung von 5-Arylidenhydantoinen (B) |
| DE3023349A1 (de) * | 1980-06-21 | 1982-01-14 | Degussa Ag, 6000 Frankfurt | Verfahren zur herstellung von 5-arylidenhydantoinen (c) |
| US4650876A (en) * | 1984-08-17 | 1987-03-17 | Stauffer Chemical Company | Hydrogenation of substituted, unsaturated hydantoins to substituted, saturated hydantoins |
| US4582903A (en) * | 1984-08-17 | 1986-04-15 | Stauffer Chemical Company | Synthesis of unsaturated hydantoins with an inexpensive catalyst |
| JPH066571B2 (ja) * | 1985-05-09 | 1994-01-26 | エーザイ株式会社 | ２−ピロリドン誘導体 |
| JPS6229570A (ja) * | 1985-07-29 | 1987-02-07 | Kanegafuchi Chem Ind Co Ltd | ３，５−ジイソプロピルベンジリデン複素環式化合物 |
| JPS6229579A (ja) * | 1985-07-29 | 1987-02-07 | Kanegafuchi Chem Ind Co Ltd | ４−チアゾリノン誘導体 |
| IL79648A (en) * | 1985-08-09 | 1991-12-12 | Lilly Co Eli | Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation |
| JP2539504B2 (ja) * | 1987-03-11 | 1996-10-02 | 鐘淵化学工業株式会社 | ヒドロキシスチレン誘導体 |
| US5208250A (en) * | 1988-05-25 | 1993-05-04 | Warner-Lambert Company | Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents |
| IE62214B1 (en) * | 1988-05-25 | 1995-01-11 | Warner Lambert Co | Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents |
| ES2088965T3 (es) * | 1989-04-07 | 1996-10-01 | Lilly Co Eli | Derivados de rodanina aril-sustituidos. |
| IL108962A (en) * | 1989-12-21 | 1996-12-05 | Lilly Co Eli | Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives a process for their preparation and pharmaceutical compositions containing them |
| US6127184A (en) * | 1998-03-07 | 2000-10-03 | Robert A. Levine | Calibration of a whole blood sample analyzer |
-
1991
- 1991-01-18 US US07/640,711 patent/US5143928A/en not_active Expired - Lifetime
- 1991-03-04 IL IL97403A patent/IL97403A0/xx unknown
- 1991-03-22 AU AU73721/91A patent/AU640468B2/en not_active Ceased
- 1991-03-25 NZ NZ237565A patent/NZ237565A/xx unknown
- 1991-03-25 FI FI911443A patent/FI103508B/fi not_active IP Right Cessation
- 1991-03-26 IE IE100691A patent/IE911006A1/en not_active IP Right Cessation
- 1991-03-26 EP EP91104787A patent/EP0449216B1/en not_active Expired - Lifetime
- 1991-03-26 NO NO911231A patent/NO302294B1/no not_active IP Right Cessation
- 1991-03-26 HU HU911001A patent/HU911001D0/hu unknown
- 1991-03-26 DE DE69116909T patent/DE69116909T2/de not_active Expired - Fee Related
- 1991-03-26 DK DK91104787.6T patent/DK0449216T3/da active
- 1991-03-26 JP JP3086109A patent/JP3028628B2/ja not_active Expired - Fee Related
- 1991-03-26 AT AT91104787T patent/ATE133945T1/de not_active IP Right Cessation
- 1991-03-26 ES ES91104787T patent/ES2082875T3/es not_active Expired - Lifetime
- 1991-03-26 CA CA002039056A patent/CA2039056C/en not_active Expired - Fee Related
- 1991-03-27 CN CN91101868A patent/CN1055180A/zh active Pending
- 1991-03-27 KR KR1019910004818A patent/KR0156533B1/ko not_active Expired - Fee Related
- 1991-03-27 PT PT97169A patent/PT97169B/pt active IP Right Grant
-
1992
- 1992-06-10 US US07/896,299 patent/US5290800A/en not_active Expired - Fee Related
-
1994
- 1994-12-09 US US08/353,166 patent/US5494927A/en not_active Expired - Fee Related
-
1996
- 1996-03-12 GR GR960400674T patent/GR3019272T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2082875T3 (es) | 1996-04-01 |
| DE69116909T2 (de) | 1996-06-13 |
| HK1005186A1 (en) | 1998-12-24 |
| DE69116909D1 (de) | 1996-03-21 |
| FI911443A0 (fi) | 1991-03-25 |
| NZ237565A (en) | 1993-02-25 |
| ATE133945T1 (de) | 1996-02-15 |
| CA2039056A1 (en) | 1991-09-28 |
| FI103508B1 (fi) | 1999-07-15 |
| US5143928A (en) | 1992-09-01 |
| DK0449216T3 (da) | 1996-07-01 |
| US5290800A (en) | 1994-03-01 |
| US5494927A (en) | 1996-02-27 |
| KR0156533B1 (ko) | 1998-11-16 |
| JPH04221371A (ja) | 1992-08-11 |
| CA2039056C (en) | 2001-09-18 |
| EP0449216B1 (en) | 1996-02-07 |
| HU911001D0 (en) | 1991-10-28 |
| CN1055180A (zh) | 1991-10-09 |
| NO911231D0 (no) | 1991-03-26 |
| JP3028628B2 (ja) | 2000-04-04 |
| NO911231L (no) | 1991-09-30 |
| FI103508B (fi) | 1999-07-15 |
| FI911443L (fi) | 1991-09-28 |
| KR910016724A (ko) | 1991-11-05 |
| PT97169B (pt) | 1998-07-31 |
| AU640468B2 (en) | 1993-08-26 |
| GR3019272T3 (en) | 1996-06-30 |
| IE911006A1 (en) | 1991-10-09 |
| AU7372191A (en) | 1991-10-03 |
| PT97169A (pt) | 1991-12-31 |
| EP0449216A1 (en) | 1991-10-02 |
| NO302294B1 (no) | 1998-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL97403A0 (en) | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them | |
| IL103875A0 (en) | Piperazinyl-and piperidinyl-cyclohexanol derivatives and pharmaceutical compositions containing the same | |
| ATE119774T1 (de) | Imidazopyridinderivate und ihre verwendung. | |
| ATE269290T1 (de) | Benzoylderivate | |
| ATE71372T1 (de) | Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel. | |
| DK0511541T3 (da) | ||
| NO903640D0 (no) | Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner. | |
| NO302365B1 (no) | Alkylderivater av trazodon med CNS-aktivitet | |
| EP0266559A3 (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
| DE69218205D1 (de) | 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOL-DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL | |
| IL95377A0 (en) | Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type | |
| DK656889A (da) | Azabicykliske derivater | |
| DK669388A (da) | Azolderivater | |
| ZA912286B (en) | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones as antiinflammatory agents |